A study links lower levels of the inhibitory neurotransmitter GABA to neuropathic pain in people with HIV, offering insight into potential pain mechanisms.
Emma Guttman, MD, PhD, discusses the promising potential of rocatinlimab in targeting the OX40-OX40 ligand pathway for atopic dermatitis treatment.
Kathryn Sullivan saw firsthand just "how limited our understanding of autoimmune diseases is," inspiring her to seek answers.
Globally, 630,000 people died from HIV-related causes in 2024, while 1.3 million people acquired HIV, including 120,000 ...
THE International Community of Women Living with HIV Eastern Africa (ICWEA) has launched a regional campaign to confront and end violence against women and girls living with HIV.Dubbed "Name It to End ...